REPORT: The Cannabis Biotech/Pharma Market Could Surpass $20 Billion by 2020

The Biotech opportunity in cannabis is one of the most intriguing and significant investment opportunities in the entire cannabis sector. Biotech companies are looking to capitalize on the anticipated growth of the cannabis-derived pharmaceutical market by levering the mounting data on the therapeutic effects of cannabis and deploying rigorous testing for quality, safety, and efficacy. Cannabinoid research, historically led by scientists in Israel, has garnered much interest in the U.S. over the past five years. Numerous studies have…